These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients. Rodes B; GarcĂa F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V; J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728 [TBL] [Abstract][Full Text] [Related]
5. Rapid screening of antiretroviral combinations. St Clair M; Pennington KN; Rooney J; Barry DW J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S24-7. PubMed ID: 8595504 [TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
7. Viral resistance and the selection of antiretroviral combinations. Larder BA J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S28-33. PubMed ID: 8595505 [TBL] [Abstract][Full Text] [Related]
8. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. Aiuti F; Mezzaroma I AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276 [TBL] [Abstract][Full Text] [Related]
9. Triple combinations: present and future. Lange JM J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S77-82. PubMed ID: 8595515 [TBL] [Abstract][Full Text] [Related]